![Jim Murray](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jim Murray
Nessuna posizione attualmente
Profilo
Jim Murray worked as the Head of Clinical Operations at Rhythm Pharmaceuticals, Inc. from 2017 to 2019, and at Merrimack Pharmaceuticals, Inc. from 2003 to 2017.
He also worked as the Vice President of Clinical at TScan Therapeutics, Inc. Additionally, he worked as the Head of Clinical Operations at Repertoire Immune Medicines, Inc. from 2019 to 2021.
Mr. Murray received his undergraduate degree from Boston College.
Precedenti posizioni note di Jim Murray
Società | Posizione | Fine |
---|---|---|
TSCAN THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 06/02/2024 |
Repertoire Immune Medicines, Inc.
![]() Repertoire Immune Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Repertoire Immune Medicines, Inc. operates as a clinical-stage biotechnology company. It focuses on the immune system to prevent, treat, and cure cancer, autoimmune disorders, and infectious diseases. The company was founded by Noubar Afeyan and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/03/2021 |
RHYTHM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/08/2019 |
MERRIMACK PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/03/2017 |
Formazione di Jim Murray
Boston College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
TSCAN THERAPEUTICS, INC. | Health Technology |
RHYTHM PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 2 |
---|---|
Merrimack Pharmaceuticals, Inc.
![]() Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Repertoire Immune Medicines, Inc.
![]() Repertoire Immune Medicines, Inc. Miscellaneous Commercial ServicesCommercial Services Repertoire Immune Medicines, Inc. operates as a clinical-stage biotechnology company. It focuses on the immune system to prevent, treat, and cure cancer, autoimmune disorders, and infectious diseases. The company was founded by Noubar Afeyan and is headquartered in Cambridge, MA. | Commercial Services |
- Borsa valori
- Insiders
- Jim Murray